Relationship between the Expression of Sodium Iodide Symporter and the Findings of ![]() |
Seok, Ju-Won
(Department of Nuclear Medicine, College of Medicine, Pusan National University)
Kim, Seong-Jang (Department of Graduate School, Pusan National University) Kwak, Hi-Suk (Department of General Surgery, College of Medicine, Pusan National University) Lee, Chang-Hun (Department of Pathology, College of Medicine, Pusan National University) Kim, In-Ju (Department of Nuclear Medicine, College of Medicine, Pusan National University) Kim, Yong-Ki (Department of Nuclear Medicine, College of Medicine, Pusan National University) Bae, Young-Tae (Department of General Surgery, College of Medicine, Pusan National University) Kim, Dong-Soo (College of Medicine, Pusan National University) |
1 | Khalkhali I, tolmos J. Role of Tc-99m sestamibiscintimammography for the evaluation of breastlesions. In: Taillerfer R, Khalkhali I, WaxmannAD, et aI, editors. Radionuclide imaging of thebreast. New York: Marcel Dekker; 1998. p.371-96. |
2 | Rao VV, Chiu ML, Krounage JF, PiwnicaWormsD. Expression of recombinant humanmultidrug resistance p-glycoprotein in insectcells confers decreased accumulation of technetium-99m sestamibi. J Nucl Med 1994;35:510-5. |
3 | Cordobes MD, Starzec A, Delmon-Moingeon L,Blanchot C, Kouyoumdiian JC, Prevest G, et al.Technetium-99m-sestamibi uptake by humanbenign and malignant breast tumor cells: Correlationwith mdr gene expression. J Nucl Med1999;37:286-9. |
4 | Kilban MT, Ajjan RA, Weetman AP, Dwyer R,McDermott EW, O'Higgins NJ, et al. Tissueiodine content and serum-mediated 1-125 uptakeblockingactivity in breast cancer. J ClinEndocrinol Metab 2000;85:1245-50. |
5 | Filetti S, Bidart J M, Arturi F, Caillou B, RussoD, Schhunberger M. Sodium/iodide symporter: akey transport system in thyroid cancer cellmetabolism. Eur J Endocrinol 1999;141:443-57. |
6 | Raspe E, Costagliola S, Ruf J, Mariotti S,Dumont JE, Ludgate M. Identification of the Na+/1 - cotransporter as a potential autoantigen in thyroid autoimmune disease. Eur J Endocrinol1995;132:399-405. |
7 | Cho JY, Leveille R, Kao R, Rousset B, ParlowAF, Burak WE Jr, et al. Hormonal regulation ofradioiodide uptake activity and Na+jl- symporterexpression in mammary glands. J Clin EndocrinolMetab 2000;85:2936-43. |
8 | Kaminsky SM, Levy 0, Salvador C, Dai G.Carrasco N. Na+/I- symporter activity is presentin membrane vesicles from thyrotropin-deprivednon-I-transporting cultured thyroid cells. ProNatl Acad Sci 1994;91:3789-93. |
9 | Spitzweg C, Joba W, Eisenmenger W, HeufelderA. Analysis of human sodium iodide symportergene expression in extrathyroidal tissues andcloning of its complementary deoxyribonucleicacids from salivary gland, mammary gland, andgastric mucosa. J Clin Endocrinol Metab 1998;83:1746-51. |
10 | Mekhmandarov S, Sandbank J, Cohen M,Lelcuk S, Lubin E. Tc-99m MIBI scintimammographyin palpable and nonpalpable breastlesions. J Nucl Med 1998;39:86-91. |
11 | Dulgeroff AJ, Hershman JM, Medical therapy for differentiated thyroid carcinoma. EndocrineRev 1994; 15:500-15. |
12 | Carrasco N. Iodide transport in the thyroidgland. Biochem Biophys Acta 1993;1154:65-82. |
13 | Cancroft ET, Goldsmith SJ. Tc-99m-pertechnetatescintigraphy as an aid in the diagnosis of breastmasses. Radiology 1973;106:441-4. |
14 | Kim SJ, Kim IJ, Kim YK, Bae YT. Tc-99mtetrofosmin scintimammography in suspectedbreast cancer patients: a comparison with Tc-99m MIBI. Medical Principles and Practice2000;9:282-9. |
15 | Dai G, Levy 0, Carrasco N. Cloning andcharacterization of the thyroid iodide transporter.Nature 1996;379:458-60. |
16 | Nakamoto Y, Saga T, Misaki T, Kobayashi H,Sato N, Ishimori T, et al. Establishment andcharacterization of a breast cancer cell lineexpressing Na+jI- symporters for radioiodideconcentrator gene therapy. J Nucl Med 2000;41:1898-904. |
![]() |